ACADIAN TIMBER CORP (ADN.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:ADN • CA0042721005

16.45 CAD
+0.34 (+2.11%)
Last: Feb 2, 2026, 07:00 PM
Fundamental Rating

4

ADN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 12 industry peers in the Paper & Forest Products industry. ADN has an excellent profitability rating, but there are concerns on its financial health. ADN has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year ADN was profitable.
  • ADN had a positive operating cash flow in the past year.
  • Each year in the past 5 years ADN has been profitable.
  • In the past 5 years ADN always reported a positive cash flow from operatings.
ADN.CA Yearly Net Income VS EBIT VS OCF VS FCFADN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

  • ADN has a better Return On Assets (2.36%) than 83.33% of its industry peers.
  • ADN has a better Return On Equity (4.19%) than 83.33% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 1.63%, ADN is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • ADN had an Average Return On Invested Capital over the past 3 years of 2.69%. This is in line with the industry average of 4.04%.
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROIC 1.63%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ADN.CA Yearly ROA, ROE, ROICADN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 16.03%, ADN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ADN has grown nicely.
  • The Operating Margin of ADN (15.01%) is better than 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of ADN has declined.
  • ADN has a better Gross Margin (30.11%) than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of ADN has remained more or less at the same level.
Industry RankSector Rank
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
ADN.CA Yearly Profit, Operating, Gross MarginsADN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ADN is destroying value.
  • The number of shares outstanding for ADN has been increased compared to 1 year ago.
  • ADN has more shares outstanding than it did 5 years ago.
  • ADN has a worse debt/assets ratio than last year.
ADN.CA Yearly Shares OutstandingADN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ADN.CA Yearly Total Debt VS Total AssetsADN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.16, we must say that ADN is in the distress zone and has some risk of bankruptcy.
  • ADN has a Altman-Z score (1.16) which is in line with its industry peers.
  • The Debt to FCF ratio of ADN is 32.89, which is on the high side as it means it would take ADN, 32.89 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 32.89, ADN perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
  • A Debt/Equity ratio of 0.33 indicates that ADN is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.33, ADN is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Altman-Z 1.16
ROIC/WACC0.25
WACC6.45%
ADN.CA Yearly LT Debt VS Equity VS FCFADN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 0.96 indicates that ADN may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.96, ADN is doing worse than 83.33% of the companies in the same industry.
  • A Quick Ratio of 0.88 indicates that ADN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.88, ADN is in line with its industry, outperforming 58.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.88
ADN.CA Yearly Current Assets VS Current LiabilitesADN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

  • The earnings per share for ADN have decreased strongly by -48.15% in the last year.
  • Measured over the past years, ADN shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.80% on average per year.
  • The Revenue for ADN has decreased by -28.86% in the past year. This is quite bad
  • Measured over the past years, ADN shows a small growth in Revenue. The Revenue has been growing by 3.05% on average per year.
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%

3.2 Future

  • ADN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.83% yearly.
  • ADN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.68% yearly.
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ADN.CA Yearly Revenue VS EstimatesADN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
ADN.CA Yearly EPS VS EstimatesADN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.58 indicates a rather expensive valuation of ADN.
  • Based on the Price/Earnings ratio, ADN is valued cheaper than 83.33% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.41, ADN is valued a bit cheaper.
  • ADN is valuated rather expensively with a Price/Forward Earnings ratio of 22.01.
  • Based on the Price/Forward Earnings ratio, ADN is valued a bit cheaper than 66.67% of the companies in the same industry.
  • ADN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 25.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 19.58
Fwd PE 22.01
ADN.CA Price Earnings VS Forward Price EarningsADN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ADN's Enterprise Value to EBITDA is on the same level as the industry average.
  • ADN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 89.36
EV/EBITDA 28.52
ADN.CA Per share dataADN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • ADN has an outstanding profitability rating, which may justify a higher PE ratio.
  • ADN's earnings are expected to decrease with -10.65% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 7.05%, ADN is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.50, ADN pays a better dividend. On top of this ADN pays more dividend than 91.67% of the companies listed in the same industry.
  • ADN's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 7.05%

5.2 History

  • The dividend of ADN decreases each year by -10.56%.
  • ADN has paid a dividend for at least 10 years, which is a reliable track record.
  • ADN has decreased its dividend recently.
Dividend Growth(5Y)-10.56%
Div Incr Years1
Div Non Decr Years1
ADN.CA Yearly Dividends per shareADN.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

  • ADN pays out 73.33% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of ADN has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP73.33%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
ADN.CA Yearly Income VS Free CF VS DividendADN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M
ADN.CA Dividend Payout.ADN.CA Dividend Payout, showing the Payout Ratio.ADN.CA Dividend Payout.PayoutRetained Earnings

ACADIAN TIMBER CORP

TSX:ADN (2/2/2026, 7:00:00 PM)

16.45

+0.34 (+2.11%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)10-29
Earnings (Next)02-11
Inst Owners8.29%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap300.87M
Revenue(TTM)85.21M
Net Income(TTM)14.13M
Analysts76.67
Price Target18.11 (10.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.05%
Yearly Dividend0.66
Dividend Growth(5Y)-10.56%
DP73.33%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.32%
Min EPS beat(2)-40.59%
Max EPS beat(2)29.95%
EPS beat(4)2
Avg EPS beat(4)36.33%
Min EPS beat(4)-40.59%
Max EPS beat(4)164.03%
EPS beat(8)5
Avg EPS beat(8)101.8%
EPS beat(12)9
Avg EPS beat(12)176.18%
EPS beat(16)11
Avg EPS beat(16)130.41%
Revenue beat(2)1
Avg Revenue beat(2)-9.79%
Min Revenue beat(2)-31.34%
Max Revenue beat(2)11.76%
Revenue beat(4)1
Avg Revenue beat(4)-7.73%
Min Revenue beat(4)-31.34%
Max Revenue beat(4)11.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.37%
Revenue beat(12)4
Avg Revenue beat(12)-1.15%
Revenue beat(16)6
Avg Revenue beat(16)-0.65%
PT rev (1m)0%
PT rev (3m)-8.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-37.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-14.33%
Valuation
Industry RankSector Rank
PE 19.58
Fwd PE 22.01
P/S 3.41
P/FCF 89.36
P/OCF 43.04
P/B 0.89
P/tB 0.91
EV/EBITDA 28.52
EPS(TTM)0.84
EY5.11%
EPS(NY)0.75
Fwd EY4.54%
FCF(TTM)0.18
FCFY1.12%
OCF(TTM)0.38
OCFY2.32%
SpS4.82
BVpS18.41
TBVpS18.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.65
Profitability
Industry RankSector Rank
ROA 2.36%
ROE 4.19%
ROCE 2.27%
ROIC 1.63%
ROICexc 1.64%
ROICexgc 1.65%
OM 15.01%
PM (TTM) 16.03%
GM 30.11%
FCFM 3.82%
ROA(3y)5.08%
ROA(5y)4.63%
ROE(3y)9.11%
ROE(5y)8.26%
ROIC(3y)2.69%
ROIC(5y)2.83%
ROICexc(3y)2.73%
ROICexc(5y)2.88%
ROICexgc(3y)2.76%
ROICexgc(5y)2.92%
ROCE(3y)3.75%
ROCE(5y)3.95%
ROICexgc growth 3Y0.45%
ROICexgc growth 5Y-5.14%
ROICexc growth 3Y0.47%
ROICexc growth 5Y-5.06%
OM growth 3Y-3.67%
OM growth 5Y-1.71%
PM growth 3Y-1.44%
PM growth 5Y1.58%
GM growth 3Y0.77%
GM growth 5Y0.08%
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 32.89
Debt/EBITDA 7.67
Cap/Depr 328.17%
Cap/Sales 4.11%
Interest Coverage 3.75
Cash Conversion 48.76%
Profit Quality 23.84%
Current Ratio 0.96
Quick Ratio 0.88
Altman-Z 1.16
F-Score3
WACC6.45%
ROIC/WACC0.25
Cap/Depr(3y)780.67%
Cap/Depr(5y)518.79%
Cap/Sales(3y)3.37%
Cap/Sales(5y)2.17%
Profit Quality(3y)61.15%
Profit Quality(5y)72.04%
High Growth Momentum
Growth
EPS 1Y (TTM)-48.15%
EPS 3Y4.63%
EPS 5Y-9.8%
EPS Q2Q%23.08%
EPS Next Y-52.71%
EPS Next 2Y-22.98%
EPS Next 3Y-10.65%
EPS Next 5Y-4.83%
Revenue 1Y (TTM)-28.86%
Revenue growth 3Y6.68%
Revenue growth 5Y3.05%
Sales Q2Q%-11.33%
Revenue Next Year-28.61%
Revenue Next 2Y-2.74%
Revenue Next 3Y-3.68%
Revenue Next 5YN/A
EBIT growth 1Y-48.28%
EBIT growth 3Y2.77%
EBIT growth 5Y1.28%
EBIT Next Year-37.55%
EBIT Next 3Y3.4%
EBIT Next 5YN/A
FCF growth 1Y-70.57%
FCF growth 3Y13.98%
FCF growth 5YN/A
OCF growth 1Y-41.26%
OCF growth 3Y28.01%
OCF growth 5YN/A

ACADIAN TIMBER CORP / ADN.CA FAQ

What is the ChartMill fundamental rating of ACADIAN TIMBER CORP (ADN.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ADN.CA.


Can you provide the valuation status for ACADIAN TIMBER CORP?

ChartMill assigns a valuation rating of 4 / 10 to ACADIAN TIMBER CORP (ADN.CA). This can be considered as Fairly Valued.


How profitable is ACADIAN TIMBER CORP (ADN.CA) stock?

ACADIAN TIMBER CORP (ADN.CA) has a profitability rating of 8 / 10.


What are the PE and PB ratios of ACADIAN TIMBER CORP (ADN.CA) stock?

The Price/Earnings (PE) ratio for ACADIAN TIMBER CORP (ADN.CA) is 19.58 and the Price/Book (PB) ratio is 0.89.


What is the financial health of ACADIAN TIMBER CORP (ADN.CA) stock?

The financial health rating of ACADIAN TIMBER CORP (ADN.CA) is 2 / 10.